-
Why Making Dramatic Moves: COLUCID PHARMACEUTICALS (NASDAQ:CLCD), CEMEX (NYSE:CX), Ocean Power Technologies (NASDAQ:OPTT), eBay Inc. (NASDAQ:EBAY), NTN Buzztime Inc. (NYSEMKT:NTN)
On Thursday shares of COLUCID PHARMACEUTICALS, INC. (NASDAQ:CLCD) closed at $8.31. On May 05, Venture capital-backed COLUCID PHARMACEUTICALS, INC. (NASDAQ:CLCD) trimmed terms for its anticipated initial public offering Tuesday, shrinking the migraine treatment developer’s expected offering size to just $55 million. CoLucid now plans to offer 5.5 million shares for $10 each, according to an […]
-
Hot Alert: MGM Resorts International (NYSE:MGM), COLUCID PHARMACEUTICALS (NASDAQ:CLCD), Casella Waste Systems Inc. (NASDAQ:CWST), Progressive (NYSE:PGR), AG Mortgage Investment Trust (NYSE:MITT)
On Wednesday shares of MGM Resorts International (NYSE:MGM) closed at $19.36. Company’s sales growth for last 5 years was 10.90% and EPS growth for next 5 years is recorded as 10.00%. MGM Resorts International (NYSE:MGM) has earned a “B-” credit rating from Morningstar. The firm’s “B-” rating indicates that the company is a high default […]
-
Active Stocks to Watch: CoLucid Pharmaceuticals Inc (NASDAQ:CLCD), Rex Energy Corporation (NASDAQ:REXX), Brookdale Senior Living Inc. (NYSE:BKD), Microsoft Corporation (NASDAQ:MSFT), Intersil (NASDAQ:ISIL)
On Wednesday shares of CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) closed at $8.00. On 30 April, CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) has announced that the first patient has been randomised in its SAMURAI study, the Company’s first Phase 3 pivotal trial of lasmiditan. Rex Energy Corporation (NASDAQ:REXX) in last trading activity increased 6.98% to close at $5.28. Company […]